First report of Fasciola hepatica seroprevalence and risk factors in European bison (Bison bonasus)
04 apr 2025
INFORMAZIONI SU QUESTO ARTICOLO
Pubblicato online: 04 apr 2025
Pagine: 227 - 232
Ricevuto: 07 ott 2024
Accettato: 24 mar 2025
DOI: https://doi.org/10.2478/jvetres-2025-0020
Parole chiave
© 2025 Anna Didkowska et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Fig. 1.

Fig. 2.

Effect of sex and site on Fasciola hepatica seropositivity in European bison_ The age variable was excluded in the model selection procedure
B | SE | Lower CI | Upper CI | Wald chi2 | P-value | |
---|---|---|---|---|---|---|
Intercept | –2.392 | 0.3611 | –3.099 | –1.684 | 43.872 | <0.001 |
Female | 1.090 | 0.3087 | 0.485 | 1.695 | 12.462 | <0.001 |
Male | 0 |
|||||
Lowland location | 1.544 | 0.3433 | 0.872 | 2.217 | 20.243 | <0.001 |
Mountain location | 0 |